Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials

James W Albers,1 Ryan Jacobson2 1Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA; 2Department of Neurology, Rush University Medical Center, Chicago, IL, USA Aim: To assess lower extremity decompression nerve surgery (DNS) to treat the consequences of diabetic dista...

Full description

Bibliographic Details
Main Authors: Albers JW, Jacobson R
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/decompression-nerve-surgery-for-diabetic-neuropathy--a-structured-revi-peer-reviewed-article-DMSO
_version_ 1797717802096787456
author Albers JW
Jacobson R
author_facet Albers JW
Jacobson R
author_sort Albers JW
collection DOAJ
description James W Albers,1 Ryan Jacobson2 1Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA; 2Department of Neurology, Rush University Medical Center, Chicago, IL, USA Aim: To assess lower extremity decompression nerve surgery (DNS) to treat the consequences of diabetic distal symmetric peripheral neuropathy (DPN). Research design and methods: MEDLINE, PubMed, and related registries were searched through December 2017 to identify randomized, quasi-randomized or observational trials that evaluated the efficacy of lower extremity DNS on pain relief (primary outcome) or other secondary outcomes. Observational studies were included, given investigators’ reluctance to use sham surgery controls. Outcome effect size was estimated, and a weighted average was calculated. Results: Eight of 23 studies evaluated pain relief, including a double-blind randomized controlled trial (with a sham surgery leg), an unblinded trial with a nonsurgical control leg, and 6 observational studies. All reported substantial pain relief post-DNS with average effect sizes between two and five. Unexpectedly, the double-blind trial showed improvement in the sham leg comparable to the DNS leg and exceeding the improvement observed in the nonsurgical leg in the unblinded study. Sensory testing showed generally favorable results supporting DNS, and nerve conduction velocities increased post-DNS relative to deterioration in controls. Ultrasound revealed fusiform nerve swelling near compression sites. Morphological results of DNS were generally favorable but inconsistent, whereas hemodynamic measures showed a positive effect on arterial parameters, as did transcutaneous oximetry (improved microcirculation). The incidence of initial and recurrent neuropathic diabetic foot ulcers appeared reduced post-DNS relative to the contralateral foot (borderline significant). Conclusion: The data remain insufficient to recommend DNS for painful DPN, given conflicting and unexpectedly positive results involving sham surgery relative to unblinded controls. The generally supportive sensory and nerve conduction results are compromised by methodological issues, whereas more favorable results support DNS to prevent new or recurrent neuropathic foot ulcers. Future studies need to clarify subject selection vis-à-vis DPN vs superimposed compressed nerves, utilize appropriate validated instruments, and readdress use of sham surgical controls in light of recent results. Keywords: diabetic neuropathy, painful neuropathy, neuropathy treatment
first_indexed 2024-03-12T08:41:40Z
format Article
id doaj.art-3715189abcb947cdaae6cd44a8b6a7a4
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-03-12T08:41:40Z
publishDate 2018-09-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-3715189abcb947cdaae6cd44a8b6a7a42023-09-02T16:43:04ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072018-09-01Volume 1149351440827Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trialsAlbers JWJacobson RJames W Albers,1 Ryan Jacobson2 1Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA; 2Department of Neurology, Rush University Medical Center, Chicago, IL, USA Aim: To assess lower extremity decompression nerve surgery (DNS) to treat the consequences of diabetic distal symmetric peripheral neuropathy (DPN). Research design and methods: MEDLINE, PubMed, and related registries were searched through December 2017 to identify randomized, quasi-randomized or observational trials that evaluated the efficacy of lower extremity DNS on pain relief (primary outcome) or other secondary outcomes. Observational studies were included, given investigators’ reluctance to use sham surgery controls. Outcome effect size was estimated, and a weighted average was calculated. Results: Eight of 23 studies evaluated pain relief, including a double-blind randomized controlled trial (with a sham surgery leg), an unblinded trial with a nonsurgical control leg, and 6 observational studies. All reported substantial pain relief post-DNS with average effect sizes between two and five. Unexpectedly, the double-blind trial showed improvement in the sham leg comparable to the DNS leg and exceeding the improvement observed in the nonsurgical leg in the unblinded study. Sensory testing showed generally favorable results supporting DNS, and nerve conduction velocities increased post-DNS relative to deterioration in controls. Ultrasound revealed fusiform nerve swelling near compression sites. Morphological results of DNS were generally favorable but inconsistent, whereas hemodynamic measures showed a positive effect on arterial parameters, as did transcutaneous oximetry (improved microcirculation). The incidence of initial and recurrent neuropathic diabetic foot ulcers appeared reduced post-DNS relative to the contralateral foot (borderline significant). Conclusion: The data remain insufficient to recommend DNS for painful DPN, given conflicting and unexpectedly positive results involving sham surgery relative to unblinded controls. The generally supportive sensory and nerve conduction results are compromised by methodological issues, whereas more favorable results support DNS to prevent new or recurrent neuropathic foot ulcers. Future studies need to clarify subject selection vis-à-vis DPN vs superimposed compressed nerves, utilize appropriate validated instruments, and readdress use of sham surgical controls in light of recent results. Keywords: diabetic neuropathy, painful neuropathy, neuropathy treatmenthttps://www.dovepress.com/decompression-nerve-surgery-for-diabetic-neuropathy--a-structured-revi-peer-reviewed-article-DMSOdiabetic neuropathypainful neuropathyneuropathy treatment
spellingShingle Albers JW
Jacobson R
Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials
Diabetes, Metabolic Syndrome and Obesity
diabetic neuropathy
painful neuropathy
neuropathy treatment
title Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials
title_full Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials
title_fullStr Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials
title_full_unstemmed Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials
title_short Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials
title_sort decompression nerve surgery for diabetic neuropathy nbsp a structured review of published clinical trials
topic diabetic neuropathy
painful neuropathy
neuropathy treatment
url https://www.dovepress.com/decompression-nerve-surgery-for-diabetic-neuropathy--a-structured-revi-peer-reviewed-article-DMSO
work_keys_str_mv AT albersjw decompressionnervesurgeryfordiabeticneuropathynbspastructuredreviewofpublishedclinicaltrials
AT jacobsonr decompressionnervesurgeryfordiabeticneuropathynbspastructuredreviewofpublishedclinicaltrials